- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06333938
Veterans Enhanced Recovery Using Integrative Treatments Around Surgery (VERITAS)
An Effectiveness-Implementation Hybrid Study on the Use of Integrative Treatments for Perioperative Symptom Management.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is an urgent need for effective, safe, and low-cost nonpharmacologic treatments for postoperative pain. This study aims to:
- assess the implementation of Music Medicine, Aromatherapy, and Battlefield Acupuncture among patients presenting for procedures at the Durham Veterans Affairs Medical Center; and,
- compare the effectiveness of these treatments, alone and in combination, versus standard clinical practice not involving any of these treatments.
Patients from the Durham Veterans Affairs Medical Center (Durham VAMC) scheduled to undergo procedures will be eligible to participate in this study. A sample of 400 veterans will be studied. We will offer treatments versus no treatment on alternate months. Recruitment will end when 200 patients have received at least one of these treatments, and 200 patients have received no treatment.
Study Type
Enrollment (Estimated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Karthik Raghunathan, MD MPH
- Phone Number: 2158507220
- Email: karthik.raghunathan@duke.edu; Karthik.Raghunathan@va.gov
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Durham Veterans Affairs Medical Center
-
Contact:
- Karthik Raghunathan, MD, MPH
- Phone Number: 919-286-6938
- Email: Karthik.Raghunathan@va.gov
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Veterans Scheduled to undergo procedures at the Durham VA
Exclusion Criteria:
- Hearing Loss
- Procedures on the Ear
- Risk of Bleeding
- Anosmia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Integrative Treatment
200 participants will receive at least one of three integrative treatments: Music Medicine, Aromatherapy, Battlefield Acupuncture
|
At least one three nonpharmacologic treatments (Music Medicine, Aromatherapy, Battlefield Acupuncture) will be delivered.
Music Medicine is the delivery of personal music players to listen to patient-preferred music before, during, or after surgical or non-surgical procedures.
Aromatherapy is the delivery of personally-preferred AromaTabs before, during, or after surgical or non-surgical procedures.
Battlefield Acupuncture is the delivery of Auricular Acutherapy by trained providers using acupuncture needles or acupressure beads before, during, or after surgical or non-surgical procedures.
|
|
Active Comparator: Standard Care
200 patients will not receive standard care without any additional integrative treatments
|
Patients will receive standard clinical care without the addition of Music Medicine, Aromatherapy, or Battlefield Acupuncture
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain and Pain Interference assessed among patients using the Defense veterans pain rating scale 2.0
Time Frame: Each day from Postoperative Day 0 to Day 5.
|
The Defense and Veterans Pain Rating Scale 2.0 utilizes a numerical rating scale enhanced by functional word descriptors, color coding, and pictorial facial expressions matched to pain levels.
Four supplemental questions measure how much pain: a) interferes with usual activity, b) interferes with sleep, c) affects mood and d) contributes to stress.
The scale for each assessment ranges from 0-10.
Three assessments will occur each day.
The daily average values will be compared at each time point.
Higher Scores represent worse outcomes.
|
Each day from Postoperative Day 0 to Day 5.
|
|
Heart Rate Variability among Patients as assessed using time and frequency domain analysis of the heart rate.
Time Frame: Each day (over 8-hour periods, 7pm and 7am) from 5 days before surgery to postoperative day 5.
|
Heart rate variability represents the change in the time interval in milliseconds between successive heartbeats.
It is a measure of input to the heart from both sympathetic and parasympathetic branches of the nervous system.
Increased heart rate variability is the better outcome.
|
Each day (over 8-hour periods, 7pm and 7am) from 5 days before surgery to postoperative day 5.
|
|
Implementation of Treatment among Patients as assessed by the Acceptability of Intervention, Appropriateness of Intervention, and Feasibility of Intervention Measures.
Time Frame: Measurement will be at three points: within the 5 day period before surgery; on the day of Surgery; and on postoperative day 5.
|
The Acceptability of Intervention measure, Appropriateness of Intervention measure, and Feasibility of Intervention Measure will be used.
Each of these three tools is a 4-item questionnaire that has been validated as a distinct and strong measure of implementation success.
Scale values for each measure range from 1-5.
The average of the three measures will be computed and compared at each time point.
Higher scores represent better outcomes.
|
Measurement will be at three points: within the 5 day period before surgery; on the day of Surgery; and on postoperative day 5.
|
|
Fidelity of Treatment among Patients as assessed by a Fidelity Checklist
Time Frame: Each day from Postoperative Day 0 to Day 5.
|
Fidelity, the degree to which an intervention was implemented as it was intended by the developers, will be measured using a fidelity instrument with three domains: adherence (adherence to each component of treatment, scale 1- 5), participant responsiveness (measured on the treatment expectation questionnaire scale 0-10), and dosage (scale 1-5).
Higher scores are better.
We will compare the average scores overall, and in each domain.
|
Each day from Postoperative Day 0 to Day 5.
|
|
Implementation of Treatment among Providers as assessed by the Acceptability of Intervention, Appropriateness of Intervention, and Feasibility of Intervention Measures.
Time Frame: On the day of surgery or within 1-day after.
|
The Acceptability of Intervention measure, Appropriateness of Intervention measure, and Feasibility of Intervention Measure will be used.
Each of these three tools is a 4-item questionnaire that has been validated as a distinct and strong measure of implementation success.
Scale values for each measure range from 1-5.
The average of the three measures will be computed and compared.
Higher scores represent better outcomes.
|
On the day of surgery or within 1-day after.
|
|
Fidelity of Treatment among Providers as assessed by a Fidelity Checklist
Time Frame: On the day of surgery or within 1-day after.
|
Fidelity, the degree to which an intervention was implemented as it was intended by the developers, will be measured using a fidelity instrument with two domains: adherence (adherence to each component of treatment, scale 1- 5), and participant responsiveness (measured on the treatment expectation questionnaire scale 0-10).
Higher scores are better.
We will compare the average scores overall, and in each domain.
|
On the day of surgery or within 1-day after.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Amount of Opioid medication received by patients assessed in average daily oral morphine equivalents.
Time Frame: Each day from Postoperative Day 0 to Day 5.
|
The amount of opioid analgesic medications received by patients as recorded in the electronic health record (inpatient setting) or as reported by patients (outpatient setting) will be summarized each day and reported in daily oral morphine equivalents.
The total amount from postoperative day 0 to day 5, and the average daily oral morphine equivalents will be measured for comparisons.
Higher amounts represent worse outcomes.
|
Each day from Postoperative Day 0 to Day 5.
|
|
Quality of Recovery among patients as measured using the Quality-of-Recovery 40 tool.
Time Frame: Preoperative on the day of surgery, and each day from Postoperative Day 0 to Day 5.
|
The Quality-of-Recovery 40 tool is a 40-item questionnaire, with each question graded on a five-point Likert scale.
Scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery).
Assessment will occur preoperatively on the day of surgery (baseline value) and each day from Postoperative Day 0 to 5. The difference between the baseline and the value each day will be compared.
|
Preoperative on the day of surgery, and each day from Postoperative Day 0 to Day 5.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 01968
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
MedtronicCompletedThoracic Surgery | Spine Surgery | Upper Extremity Surgery | Lower Extremity Surgery | Intracranial Surgery | Extracranial Surgery | Intratemporal Surgery | Extratemporal Surgery | Neck SurgeryGermany
-
[Redacted]3M; Solventum US LLCWithheldAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Baylor Research InstituteChiesi USA, Inc.CompletedSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Maquet Cardiopulmonary GmbHNAMSATerminatedCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain, Italy
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Centre Hospitalier Universitaire de NīmesNot yet recruitingAnesthesia, Local | Foot Surgery | Hand Surgery | Walant SurgeryFrance
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Eurosets S.r.l.RecruitingCardiac Surgery | Cardiopulmonary Bypass | Heart Surgery | Aortic Valve Surgery | Cannulation | Coronary Surgery With Cardiopulmonary Bypass | Coronary Surgery | Arterial Cannulation | Venous CannulationItaly
Clinical Trials on Nonpharmacologic Treatment
-
National Institute of Medical Sciences and Nutrition...WithdrawnMild Cognitive ImpairmentMexico
-
Kutahya Health Sciences UniversityCompletedNursing Caries | Nurse's Role | Newborn IllnessTurkey
-
Hypnalgesics, LLCBoston Medical Center; Ohio State University; Tufts Medical CenterCompletedClaustrophobia | Complication of Diagnostic ProcedureUnited States
-
Hypnalgesics, LLCDuke University; Ohio State UniversityCompletedClaustrophobia | Complication of Diagnostic ProcedureUnited States
-
General Hospital of Chinese Armed Police ForcesUnknownCoronary Artery DiseaseChina
-
PfizerCompleted
-
PfizerCompleted
-
Chiesi Farmaceutici S.p.A.Completed
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States
-
JW PharmaceuticalCompletedHealthyKorea, Republic of